MTOR and Li-Fraumeni syndrome: GBOs have also been used to study response to chimeric antigen T (CAR-T) cell immunotherapy in the setting of the EGFRvIII variant (111), mTOR inhibitors in PTEN loss (112), and STAT inhibitors in Li-Fraumeni syndrome (113).